At Takeda Oncology, the oncology business unit brand of Takeda Pharmaceutical Company Limited, we endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients.
This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, we are finding innovative ways to improve the treatment of cancer.
We've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though we've made great strides in our fight against cancer, we are determined to do more — to work harder and to reach higher. We continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that we are today.
We know that our mission is not a quick or simple one, but we are up to the task: we aspire to cure cancer.
"Despite the progress made in the fight against cancer, serious unmet needs persist across many forms of the disease. Our deep understanding of patient needs, scientific rigor, resources and agile business model optimally equip us to work quickly to meet the diverse needs of cancer patients, healthcare providers and systems around the world, and bring the next generation of cancer treatments to patients who need them."Christophe Bianchi, M.D.
President, Global Oncology Business Unit